Nexkem Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 Cr
- Revenue Growth 107.84%
- Profit Growth -123.45%
- Ebitda -174.58%
- Net Worth -460.74%
- Total Assets 8.64%
About Nexkem Biotech
Nexkem Biotech Private Limited (NBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 25 September 2020 (Four years and four months 27 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹2.50 Cr.
Ram Chhaba and Devendra Dagur serve as directors at the Company.
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233HP2020PTC008107
- Company No.
008107
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Nexkem Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Chhaba  | Director | 25-Sep-2020 | Current |
| Devendra Dagur | Director | 25-Sep-2020 | Current |
Financial Performance of Nexkem Biotech.
Nexkem Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 107.84% increase. The company also saw a substantial fall in profitability, with a 123.45% decrease in profit. The company's net worth observed a substantial decline by a decrease of 460.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexkem Biotech?
Unlock access to Nexkem Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Nexkem Pharmaceuticals Private LimitedRam Chhaba is a mutual person
Nutrock Nutrition (India) Private LimitedRam Chhaba is a mutual person
- Nexkem Foundation
Ram Chhaba is a mutual person
Charges (Loans)
₹25.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 2.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2022 | Axis Bank Limited | ₹2.50 Cr | Open |
How Many Employees Work at Nexkem Biotech?
Nexkem Biotech has a workforce of 23 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexkem Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexkem Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.